skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 22,200  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Refined by: Journal Title: Oncotarget remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Altered glycosylation of several metastasis-associated glycoproteins with terminal GalNAc defines the highly invasive cancer cell phenotype
Material Type:
Article
Add to My Research

Altered glycosylation of several metastasis-associated glycoproteins with terminal GalNAc defines the highly invasive cancer cell phenotype

Oncotarget, 2022, Vol.13 (1), p.73-89

Copyright: © 2022 Khosrowabadi et al. ;ISSN: 1949-2553 ;EISSN: 1949-2553 ;DOI: 10.18632/ONCOTARGET.28167 ;PMID: 35028012

Full text available

2
Molecular characterization of lung squamous cell carcinoma tumors reveals therapeutically relevant alterations
Material Type:
Article
Add to My Research

Molecular characterization of lung squamous cell carcinoma tumors reveals therapeutically relevant alterations

Oncotarget, 2021-03, Vol.12 (6), p.578-588

Copyright: © 2021 Joshi et al. ;ISSN: 1949-2553 ;EISSN: 1949-2553 ;DOI: 10.18632/ONCOTARGET.27905 ;PMID: 33796225

Full text available

3
Influence of high altitude on the expression of HIF-1 and on the prognosis of Ecuadorian patients with gastric adenocarcinoma
Material Type:
Article
Add to My Research

Influence of high altitude on the expression of HIF-1 and on the prognosis of Ecuadorian patients with gastric adenocarcinoma

Oncotarget, 2022-09, Vol.13 (1), p.1043-1053

Copyright: © 2022 Barrera et al. ;ISSN: 1949-2553 ;EISSN: 1949-2553 ;DOI: 10.18632/oncotarget.28275

Full text available

4
Eltrombopag and its iron chelating properties in pediatric acute myeloid leukemia
Material Type:
Article
Add to My Research

Eltrombopag and its iron chelating properties in pediatric acute myeloid leukemia

Oncotarget, 2021-07, Vol.12 (14), p.1377-1387

Copyright: © 2021 Argenziano et al. ;ISSN: 1949-2553 ;EISSN: 1949-2553 ;DOI: 10.18632/oncotarget.28000 ;PMID: 34262648

Full text available

5
Glypican-3 (GPC3) is associated with MCPyV-negative status and impaired outcome in Merkel cell carcinoma
Material Type:
Article
Add to My Research

Glypican-3 (GPC3) is associated with MCPyV-negative status and impaired outcome in Merkel cell carcinoma

Oncotarget, 2022-08, Vol.13 (1), p.960-967

Copyright: © 2022 Muralidharan et al. ;ISSN: 1949-2553 ;EISSN: 1949-2553 ;DOI: 10.18632/oncotarget.28260 ;PMID: 35937502

Full text available

6
Continuous treatment with abemaciclib leads to sustained and efficient inhibition of breast cancer cell proliferation
Material Type:
Article
Add to My Research

Continuous treatment with abemaciclib leads to sustained and efficient inhibition of breast cancer cell proliferation

Oncotarget, 2022-07, Vol.13 (1), p.864-875

Copyright: © 2022 Torres-Guzmán et al. ;ISSN: 1949-2553 ;EISSN: 1949-2553 ;DOI: 10.18632/oncotarget.28249 ;PMID: 35813283

Full text available

7
Association of high-sensitivity C-reactive protein and odds of breast cancer by molecular subtype: analysis of the MEND study
Material Type:
Article
Add to My Research

Association of high-sensitivity C-reactive protein and odds of breast cancer by molecular subtype: analysis of the MEND study

Oncotarget, 2021-06, Vol.12 (13), p.1230-1242

Copyright: © 2021 Gupta et al. ;ISSN: 1949-2553 ;EISSN: 1949-2553 ;DOI: 10.18632/oncotarget.27991 ;PMID: 34194621

Full text available

8
Deciphering miR-520c-3p as a probable target for immunometabolism in non-small cell lung cancer using systems biology approach
Material Type:
Article
Add to My Research

Deciphering miR-520c-3p as a probable target for immunometabolism in non-small cell lung cancer using systems biology approach

Oncotarget, 2022-05, Vol.13 (1), p.725-746

Copyright: © 2022 Gulhane et al. ;ISSN: 1949-2553 ;EISSN: 1949-2553 ;DOI: 10.18632/oncotarget.28233 ;PMID: 35634241

Full text available

9
Loss of DRO1/CCDC80 in the tumor microenvironment promotes carcinogenesis
Material Type:
Article
Add to My Research

Loss of DRO1/CCDC80 in the tumor microenvironment promotes carcinogenesis

Oncotarget, 2022-04, Vol.13 (1), p.615-627

Copyright: © 2022 Christian et al. ;ISSN: 1949-2553 ;EISSN: 1949-2553 ;DOI: 10.18632/oncotarget.28084 ;PMID: 35422964

Full text available

10
A platform for locoregional T-cell immunotherapy to control HNSCC recurrence following tumor resection
Material Type:
Article
Add to My Research

A platform for locoregional T-cell immunotherapy to control HNSCC recurrence following tumor resection

Oncotarget, 2021-06, Vol.12 (13), p.1201-1213

Copyright: © 2021 Sharon et al. ;ISSN: 1949-2553 ;EISSN: 1949-2553 ;DOI: 10.18632/oncotarget.27982 ;PMID: 34194619

Full text available

11
Sequencing of BRCA1/2 -alterations using NGS-based technology: annotation as a challenge
Material Type:
Article
Add to My Research

Sequencing of BRCA1/2 -alterations using NGS-based technology: annotation as a challenge

Oncotarget, 2022-03, Vol.13 (1), p.464-475

Copyright: © 2022 Ebner et al. ;ISSN: 1949-2553 ;EISSN: 1949-2553 ;DOI: 10.18632/oncotarget.28213 ;PMID: 35251494

Full text available

12
Impact of combining vitamin C with radiation therapy in human breast cancer: does it matter?
Material Type:
Article
Add to My Research

Impact of combining vitamin C with radiation therapy in human breast cancer: does it matter?

Oncotarget, 2022-02, Vol.13 (1), p.439-453

Copyright: © 2022 Khazaei et al. ;ISSN: 1949-2553 ;EISSN: 1949-2553 ;DOI: 10.18632/oncotarget.28204 ;PMID: 35222809

Full text available

13
Metanephric adenoma: molecular study and review of the literature
Material Type:
Article
Add to My Research

Metanephric adenoma: molecular study and review of the literature

Oncotarget, 2022-02, Vol.13 (1), p.387-392

Copyright: © 2022 Rodríguez-Zarco et al. ;ISSN: 1949-2553 ;EISSN: 1949-2553 ;DOI: 10.18632/oncotarget.28192 ;PMID: 35198098

Full text available

14
A comparison of 64Cu-labeled bi-terminally PEGylated A20FMDV2 peptides targeting integrin ανβ6
Material Type:
Article
Add to My Research

A comparison of 64Cu-labeled bi-terminally PEGylated A20FMDV2 peptides targeting integrin ανβ6

Oncotarget, 2022-02, Vol.13 (1), p.360-372

Copyright: © 2022 Huynh et al. ;ISSN: 1949-2553 ;EISSN: 1949-2553 ;DOI: 10.18632/oncotarget.28197 ;PMID: 35186193

Full text available

15
Cytogenetic and molecular analyses of 291 gastrointestinal stromal tumors: site-specific cytogenetic evolution as evidence of pathogenetic heterogeneity
Material Type:
Article
Add to My Research

Cytogenetic and molecular analyses of 291 gastrointestinal stromal tumors: site-specific cytogenetic evolution as evidence of pathogenetic heterogeneity

Oncotarget, 2022, Vol.13 (1), p.508-517

Copyright: © 2022 Gorunova et al. ;info:eu-repo/semantics/openAccess ;ISSN: 1949-2553 ;EISSN: 1949-2553 ;DOI: 10.18632/oncotarget.28209 ;PMID: 35284037

Full text available

16
Diverse transcriptional regulation and functional effects revealed by CRISPR/Cas9-directed epigenetic editing
Material Type:
Article
Add to My Research

Diverse transcriptional regulation and functional effects revealed by CRISPR/Cas9-directed epigenetic editing

Oncotarget, 2021-08, Vol.12 (17), p.1651-1662

Copyright: © 2021 Vizoso and Rheenen. ;ISSN: 1949-2553 ;EISSN: 1949-2553 ;DOI: 10.18632/oncotarget.28037 ;PMID: 34434494

Full text available

17
Epigallocatechin-3-gallate modulates Tau Post-translational modifications and cytoskeletal network
Material Type:
Article
Add to My Research

Epigallocatechin-3-gallate modulates Tau Post-translational modifications and cytoskeletal network

Oncotarget, 2021-05, Vol.12 (11), p.1083-1099

Copyright: © 2021 Sonawane and Chinnathambi. ;ISSN: 1949-2553 ;EISSN: 1949-2553 ;DOI: 10.18632/oncotarget.27963 ;PMID: 34084282

Full text available

18
[ 18 F]FDG and [ 18 F]FES positron emission tomography for disease monitoring and assessment of anti-hormonal treatment eligibility in granulosa cell tumors of the ovary
Material Type:
Article
Add to My Research

[ 18 F]FDG and [ 18 F]FES positron emission tomography for disease monitoring and assessment of anti-hormonal treatment eligibility in granulosa cell tumors of the ovary

Oncotarget, 2021-03, Vol.12 (7), p.665-673

Copyright: © 2021 Roze et al. ;ISSN: 1949-2553 ;EISSN: 1949-2553 ;DOI: 10.18632/oncotarget.27925 ;PMID: 33868587

Full text available

19
Clofarabine-based reduced intensity conditioning regimen with peripheral blood stem cell graft and post-transplant cyclophosphamide in adults with myeloid malignancies
Material Type:
Article
Add to My Research

Clofarabine-based reduced intensity conditioning regimen with peripheral blood stem cell graft and post-transplant cyclophosphamide in adults with myeloid malignancies

Oncotarget, 2018-09, Vol.9 (71), p.33528-33535

Copyright: © 2018 Chevallier et al. 2018 ;ISSN: 1949-2553 ;EISSN: 1949-2553 ;DOI: 10.18632/oncotarget.26083 ;PMID: 30323896

Full text available

20
Damage-associated molecular pattern (DAMP) activation in melanoma: investigation of the immunogenic activity of 15-deoxy, Δ12,14 prostamide J2
Material Type:
Article
Add to My Research

Damage-associated molecular pattern (DAMP) activation in melanoma: investigation of the immunogenic activity of 15-deoxy, Δ12,14 prostamide J2

Oncotarget, 2020-12, Vol.11 (52), p.4788-4802

Copyright: © 2020 Elhassanny et al. ;ISSN: 1949-2553 ;EISSN: 1949-2553 ;DOI: 10.18632/oncotarget.27856 ;PMID: 33447347

Full text available

Results 1 - 20 of 22,200  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (35)

Refine My Results

Creation Date 

From To
  1. Before 2012  (87)
  2. 2012 To 2014  (1,171)
  3. 2015 To 2017  (17,391)
  4. 2018 To 2021  (3,425)
  5. After 2021  (127)
  6. More options open sub menu

Subject 

  1. Research Paper  (19,141)
  2. Oncology  (18,719)
  3. Cell Biology  (18,150)
  4. Life Sciences & Biomedicine  (18,150)
  5. Science & Technology  (18,150)
  6. Humans  (12,972)
  7. Female  (7,179)
  8. Animals  (6,221)
  9. Male  (5,695)
  10. Cell Line, Tumor  (5,680)
  11. Mice  (4,405)
  12. Middle Aged  (4,086)
  13. Aged  (3,209)
  14. Prognosis  (3,013)
  15. Adult  (2,797)
  16. Gene Expression Regulation, Neoplastic  (2,524)
  17. Mice, Nude  (2,127)
  18. Xenograft Model Antitumor Assays  (1,973)
  19. Signal Transduction  (1,845)
  20. Cell Proliferation  (1,807)
  21. More options open sub menu

Language 

  1. Japanese  (4,003)
  2. Norwegian  (10)
  3. French  (1)
  4. More options open sub menu

Searching Remote Databases, Please Wait